Marshall Edwards, Inc.'s Investigational Drug Triphendiol (NV-196) Demonstrates Potent Activity Against Biliary Cancers
April 13, 2008 16:00 ET | Marshall Edwards, Inc.
SAN DIEGO, CA--(Marketwire - April 13, 2008) - Pre-clinical studies presented here today at the annual meeting of the American Association for Cancer Research demonstrate that Marshall Edwards,...
Data to Be Presented at AACR Reveals That the Marshall Edwards' Compound Triphendiol May Aid in Treatment of Pancreatic Cancer
March 25, 2008 08:02 ET | Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - March 25, 2008) - The abstract for a "late breaking" presentation at the Annual Meeting of the American Association for Cancer Research, April 12-16, San Diego, Calif.,...